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Abstract
Background: Leptospirosis is an important reemerging zoonosis, with more than half a million cases reported
annually, and is caused by pathogenic Leptospira species. Development of a universal vaccine is one of the major
strategic goals to overcome the disease burden of leptospirosis. In this study, a chimeric multi-epitope protein-based
vaccine was designed and tested for its potency to induce a specific immune response and provide protection against
L. interrogans infection.
Results: The protein, containing four repeats of six T- and B-cell combined epitopes from the leptospiral outer
membrane proteins, OmpL1, LipL32 and LipL21, was expressed and purified. Western blot analysis showed that the
recombinant protein (named r4R) mainly expressed in a soluble pattern, and reacted with antibodies raised in rabbit
against heat-killed Leptospira and in guinea pigs against the r4R vaccine. Microscopic agglutination tests showed that
r4R antisera was immunological cross-reactive with a range of Chinese standard reference strains of Leptospira
belonging to different serogroups. In guinea pigs, the r4R vaccine induced a Th1-biased immune response, as
reflected by the IgG2a/IgG1 ratio and cytokine production of stimulated splenocytes derived from immunized
animals. Finally, r4R-immunized guinea pigs showed increased survival of lethal Leptospira challenges compared
with PBS-immunized animals and tissue damage and leptospiral colonization of the kidney were reduced.
Conclusions: The multi-epitope chimeric r4R protein is a promising antigen for the development of a universal
cross-reactive vaccine against leptospirosis.
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Background
Leptospira interrogans is the causative agent of zoonotic
leptospirosis, which affects humans in both developing
and developed countries. It is a major public health
problem in many areas, particularly after floods and
heavy monsoons. Globally, it has is estimated that 0.1 to
1 per 100,000 people living in temperate climates are
affected each year, with the numbers increasing to ten or
more per 100,000 people living in tropical climates
(according to World Health Organization, The Global
Burden of Leptospirosis). In China, between 2002 and
2007 approximately 1500 people were infected with L.
interrogans of which 50 died [1]. People are generally
infected by contaminated water or soil sources
through exposure of wounds in the skin or through
exposure of the mucosal layers [2]. The symptoms
following infection can vary from a mild febrile illness
to more severe icteric disease, which is characterized
by potentially fetal renal and liver failure [3].
Despite the constant progress of antimicrobial thera-
peutics, vaccination is still expected to be the most ef-
fective method to protect people that come in close
contact with infected animals or environments. Both
inactivated and attenuated vaccines have been used in
animals or even in humans. However, these vaccines are
associated with high rates of side-effects, such as aches
and anaphylaxis, and they confer only short-term
serovar-specific immunity [4, 5]. Currently, studies on
developing leptospirosis subunit vaccines are particularly
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focused on bacterial motility, lipopolysaccharides (LPSs),
lipoproteins, outer-membrane proteins (OMPs) and
potential virulence factors. However, the protective ef-
ficacy of these candidates in experimental animals is
low (40–75 %) [6]. Thus far, the most promising subunit
vaccine candidates are the Lig proteins, which have been
shown to confer high-level protection, approaching 100 %
in mice and hamsters [7–10]. However, whether the Lig
proteins are able to elicit cross-protective immunity to a
range of serovar remains to be determined, since the simi-
larity of the amino acid sequence of this protein between
different Leptospira spp. is 70–100 % [6]. Since the cur-
rently available vaccines are characterized by a short dur-
ation of immunity, side-effects or serovar specificity, it is
important to develop a universal leptospirosis vaccine with
high efficiency and low toxicity.
For this purpose, we screened different Leptospira se-
rotypes for conserved surface-exposed antigens. Bacterial
outer membrane proteins (OMPs) are a major target of
the immune system in a variety of infectious diseases
and they have been suggested as candidates for diagnosis
and immunization [4]. In Leptospira, three classes of
these OMPs have been identified: 1) lipoproteins, which
are the most abundant class and include proteins such
as LipL32, LipL41 and LipL21 [11–13]; 2) trans-
membrane proteins, which include OmpL1 [14]; and 3)
peripheral membrane proteins, which include LipL45
[15]. In our previously studies we have identified that
OmpL1, LipL32 and LipL21 are expressed in all the
pathogenic strains of 15 serovar/serogroup standard ref-
erence strains of Leptospira in China [16–18]. Further-
more, production of these proteins was down-regulated
(about 10–50 fold) in host-adapted Leptospira [19], sug-
gesting that these proteins might not be involved in the
pathogenesis of Leptospira after it gains entry into the
mammalian host, which indicates that these OMPs are
safe vaccine candidates.
Leptospira contains over 200 pathogenic serovars,
which are divided over 25 serogroups. The diversity of
Leptospira is also reflected in its OMPs, which are genet-
ically diverse between different serogroups [16–18]. In
addition, given the large size of OMPs, conserved epi-
topes might also be sterically blocked. For these reasons,
an OMP vaccine might still provide only minimal pro-
tection against a heterologous Leptospira infection.
Alternatively, conserved functional OMP epitopes could
be used for the development of a peptide vaccine [20].
However, it is difficult to develop an epitope-based pep-
tide vaccine for human clinical trials, because of the
technical limitations or economic reasons in synthesiz-
ing large quantities of highly purified peptides. Our
strategy to overcome these difficulties was to develop a
multi-epitope chimeric protein that is composed of the
immunodominant epitopes from the OMPs OmpL1,
LipL32 and LipL21, which are separated by a tetragly-
cine linker. The selected epitopes consisted of both
B-cell epitopes, which are essential for protective anti-
body response, and T-cell epitopes, which serve to induce
a cellular immune response.
Results
Expression, purification and immunogenicity of the
chimeric r4R protein
Based on the sequences of screened epitopes [21, 22], a
gene fragment containing six selected epitope sequences
was synthesized (Additional file 1) and cloned as four
consecutive repeats in an expression vector, thereby
forming a single chimeric multi-epitope encoding gene.
The protein was successfully expressed in Escherichia
coli BL21 (DE3) and purified. SDS-PAGE results showed
that the full-length 64 kD protein was induced by IPTG
and present in the soluble fraction of lysed E. coli BL21
(DE3) cells (Fig. 1a). Furthermore, SDS-PAGE analysis
of the purified protein under native conditions showed a
single band at 64 kD (Fig. 1a). The yield of the protein
purification process was approximately 10.2 mg of protein
from 1 l culture. The protein sample was passed through
a Detoxi-Gel column, which contains a modified poly-
myxin prime B (PMB) that removes lipopolysaccharide
(LPS) contaminations. No residual LPS was detected in
the protein extract using a limulus test, which has a detec-
tion sensitivity of 10 pg (data not shown). The purified
recombinant protein was named r4R.
To evaluate reactivity of r4R with antibodies raised in
rabbits against heat-killed L. interrogans strain Lai,
Western blot analysis was performed. Antibodies raised
in rabbits against heat-killed L. interrogans were showing
a strong interaction with r4R (Fig. 1b), indicating that
the epitopes of r4R are present on the surface of L. inter-
rogans. To evaluate the immunogenicity of r4R, guinea
pigs were immunized with r4R and the collected serum
analyzed. Western analysis showed that the chimeric
multi-epitope r4R protein was able to induce an antigen-
specific humoral immune response (Fig. 1c). The immu-
nodiffusion titer of the antisera against the chimeric r4R
protein was 1:8.
To evaluate the polarity of the immune response
against r4R, antigen-specific IgG subtype (IgG1 and
IgG2a) responses in the sera of vaccinated and control
guinea pigs were measured by ELISA. The results
showed that although the levels of both IgG1 and IgG2a
were increased in the sera of animals immunized with
the recombinant protein compared with the control sera
from PBS treated animals, the level of IgG2a was higher
than that of IgG1 (Fig. 2). The elevated IgG2a/IgG1 ratio
points to a Th1 polarized immune response in the
r4R-immunized guinea pigs. To determine the cross-
reactivity of serum obtained from r4R-immunized
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guinea pigs, MAT analysis was performed using the
most commonly encountered serogroups of L. interro-
gans in China, namely Icterohaemorrhagiae, Pomona,
Canicola, Hebdomadis, Autumnalis, Grippotyphosa
and Australis. Serum from the r4R-immunized guinea
pigs was able to cross-agglutinate each of the L. inter-
rogans serogroup-specific standard reference strains
with titers ranging from 1:80 to 1:320 (Table 1).
These results indicate that r4R is an immunological
cross-reactive protein, which is important for the
coverage of a leptospiral vaccine.
Lymphocyte proliferation and cytokine production in
response to chimeric r4R protein
Lymophocytes from r4R-immunized guinea pigs were
stimulated ex vivo with the r4R protein and analyzed for
proliferation and cytokine production. Lymphocytes
stimulated with r4R showed a significantly higher prolif-
eration response compared with the controls (Fig. 3a).
The supernatant of the r4R stimulated lymphocytes was
analyzed for IFN-γ and IL-4 cytokine levels by ELISA.
IFN-γ production was 20-fold higher in lymphocytes
that were isolated from animals immunized with the
chimeric r4R protein and subsequently stimulated with
r4R compared with the controls (Fig. 3b). No significant
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Fig. 1 Characterization of the expressed and purified chimeric r4R protein. a SDS-PAGE analysis of the expression and purification steps of the r4R
protein. Pellet (lane 1 and 3) and supernatant (lane 2 and 4) fractions of lysates from E. coli BL21 (DE3) cells containing the empty vector pET28a
(lane 1 and 2) or pET28a-4R (lane 3 and 4) were electrophoresed in a 10 % SDS-PAGE gel. M indicates the protein ladder. Lane 5 contains the
purified recombinant 4R protein. b Anti-Leptospira Western blot analysis. The purified chimeric r4R protein was run on a SDS-PAGE gel and
transferred to a PVDF membrane. Serum from heat-killed L. interrogans strain Lai immunized rabbits was used as a primary antibody to
detect r4R. Serum from PBS injected rabbits was used as control. c Anti-r4R Western analysis. The purified chimeric r4R protein was run
on SDS-PAGE gel and transferred to a PVDF membrane. Serum from guinea pigsimmunized with PBS (negative control) or chimeric protein, were used
as primary antibody
Fig. 2 Response of IgG subclasses on the chimeric protein. IgG
subclasses induced by the chimeric protein in guinea pigs were
detected by ELISA
Table 1 MAT analysis of sera from r4R-immunized guinea pigs
against various L. interrogans serogroups
Serogroup Strain MAT titer (1:N) Normal
Icterohaemorrhagiae 56,601 320 -
Grippotyphosa 56,609 80 -
Autumnalis 56,606 160 -
Pomona 56,608 160 -
Australis 56,607 80 -
Hebdomadis 56,610 160 -
Canicola 56,603 80 -
Sejroe 56,635 80 -
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differences in IL-4 cytokine production were observed
(Fig. 3b), indicating again that r4R specifically stimulates
a Th1-biased immune response.
Protective efficacy of the chimeric r4R protein vaccine
To investigate whether the chimeric r4R protein is able
to induce protective immunity against a lethal L. interro-
gans infection, guinea pigs were immunized and chal-
lenged with L. interrogans strain Lai, for which the LD50
was determined at 1 × 108. PBS-immunized guinea pigs
challenged with a 2 × LD50 died within 8–10 post-
infection, while 80 % (4/5) of the r4R-immunized guinea
pigs survived challenges with this dose. Liver, kidney and
lung tissues of the challenged PBS-immunized guinea
pigs showed severe leptospirosis symptoms, including
necrosis (Fig. 4). In the kidney and liver, severe lesions
were observed, including hemorrhages, while histo-
pathological lesions in the kidney showed renal tubular
necrosis with occasional polymorphonuclear cell infiltra-
tion and loss of normal liver architecture. In contrast,
Fig. 3 Proliferative and immune responses of splenocytes immunized with chimeric protein. Guinea pigs were immunized with the chimeric r4R
protein. Ten days after the last immunization, the splenocytes were isolated, stimulated with the r4R protein and cultured for 72 h. a Splenocyte
proliferation analysis of PBS, ConA and r4R stimulated splenocytes. b ELISA measurements of IL-4 and INF-γ secreted by pooled control, ConA and
































Fig. 4 Histopathological effects of Leptospira challenges on immunized guinea pig tissues. Representative images of liver, kidney and lung tissues
of healthy guinea pigs (a) or guinea pigs immunized with the chimeric r4R protein (b) or PBS (c) and challenged with L. interrogans strain Lai.
Tissues were stained with hematoxylin and eosin
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liver, kidney and lung tissues of r4R-immunized animals
showed only mild edema symptoms (Fig. 4), and there
was little or no evidence of lesion formation. Further-
more, in Fontana silver-stained kidney samples, no Lep-
tospira were detected in the r4R-immunized animals,
while many Leptospira were detected in the samples
from PBS-immunized animals (Fig. 5a). In addition, after
incubation of the lysed kidney samples in EMJH
medium at 30 °C for 28 days, floccules were observed in
the EMJH medium by tungsten lamp analysis of the
PBS-immunized guinea pig samples, while none were
detected in the samples from r4R-immunized animals
(data not shown). Finally, no leptospires were detected
in the urine samples of r4R-immunized guinea pigs,
while some were encountered in the urine samples of
PBS-immunized animals (Fig. 5b). Together, these re-
sults indicate that immunization of guinea pigs with the
chimeric multi-antigen r4R protein provides protection
of the animals against lethal challenges of Leptospira
and prevents severe tissue damage.
Discussion
L. interrogans is a bacterial pathogen that causes wide-
spread disease in both animals and humans. Leptospir-
osis poses a significant public health problem since it is
potentially fatal due to the damage it can cause to mul-
tiple organs, including the liver, lungs, kidney and brain
[23]. Leptospirosis is prevalent throughout China, except
for some of the Western provinces (Xinjiang, Xizang,
Qinghai, Gansu and Ningxia). Particularly hard hit are
the regions in the Yangtze River basin, such as the prov-
inces Sichuan, Hubei and Hunan and the area south of
the Five Ridges. The most commonly encountered L.
interrogans serogroups in China are Icterohaemorrha-
giae, Pomona, Canicola, Hebdomadis, Autumnalis, Grip-
potyphosa and Australis [5]. The currently available and
widely used vaccine against leptospirosis is a multivalent
inactivated whole-cell vaccine. However, this vaccine
shows high side-effects and elicits little cross-protection
against strains from different serovars. Therefore, a new
effective and safe vaccine that is able to provide cross-
protection of at risk humans or animals is urgently
needed.
Currently, vaccine research against Leptospira is fo-
cused on the discovery of cross-reactive conserved anti-
gens that are able to provide long-term protection
against a broad range of Leptospira spp. [24]. It is well
established that OMPs show a high degree of conserva-
tion in Leptospira spp.. Furthermore, they are immuno-
dominant antigens in both humans and animals and
contain multiple B- and T-cell epitopes that are able to
elicit both neutralizing antibody response and T-cell me-
diated immunity [25]. Therefore, OMPs are likely the
most successful candidate antigens for potential subunit
vaccines. An ideal peptide-based vaccine should also
contain both B- and T-cell epitopes. In our previous re-
search, we identified six B- and T-cell combined immu-
nodominant epitopes in the OMPs OmpL1, LipL32 and
LipL21 from Leptospira, and tested whether they were
able to induce specific immune responses [21, 22]. Con-
sidering the diversity among Leptospira serovars, these
epitopes fragments are much conserved and show a high
degree of homology among 15 serovar/serogroup stand-
ard reference strains of Leptospira in China. These six
CK                          r4R                         PBS
A
B
Fig. 5 Colonization of L. interrogans in chimeric r4R immunized guinea pigs. Representative images of kidney lysates (a) or urine samples (b) that
were collected from healthy control guinea pigs (CK) of guinea pigs immunized with r4R or PBS and subsequently challenged with L. interrogans
strain Lai. All samples were strained with the Fontana silver staining method and observed using an optical microscope
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selected epitopes are only about 20 amino acids in
length, which complicates mass production and makes
them susceptible to host hydrolysis mechanisms. There-
fore, in the current study, a gene fragment was synthe-
sized that encoded all six epitopes separated by a four
glycine spacer and which was codon optimized for ex-
pression in E. coli. This gene fragment was cloned as
four consecutive copies in an expression vector and pro-
duced a 64 kD fusion protein. This recombinant protein
was expressed in the soluble fraction, which is important
to maintain its antigenicity and immunogenicity.
Antibodies are a major contributor to the phagocytosis
and destruction of pathogenic Leptospira by macro-
phages [26]. Our r4R protein showed a strong immuno-
genicity in guinea pigs, which resulted in the production
of high levels of specific antibodies. This is essential for
the killing of Leptospira through complement-mediated
lysis or through opsonin-dependent phagocytosis. To
confirm that antibodies were reactive with a variety of
leptospiral serovars, the MAT test was used, which is
considered as the “golden standard” in the serodiagnosis
of leptospirosis and the serological classification of Lep-
tospira species. Our results revealed that the antisera ob-
tained after immunization with r4R were able to
agglutinate all standard reference strains of Leptospira in
China, with MAT titers up to 1:320. Therefore, we ex-
pect that antibodies raised against our r4R protein are
able to provide cross-protection against a wide variety of
Leptospira serovars, although this still requires further
confirmation using animal experiments.
Protective immunity to Leptospira is highly serovar-
specific, which points to a dominant role for humoral
immunity in the protection against Leptospira infection.
However, recently it was shown that during an infection
with Leptospira, cellular immunity still plays an import-
ant role in the control of disease [27]. Immunization
with our r4R multi-epitope chimeric protein resulted in
a dominant Th1 response, which was reflected by the
yield of antigen-specific IgG subtypes (IgG2a > IgG1). A
Th1 response generally induces IgG2a expression, while
a Th2 response results predominantly in IgG1 production
[28]. Besides mediating intracellular killing of a variety of
pathogenic microorganisms, Th1 cells also stimulate B
cells to produce antibodies that are important for mucosal
immunity, such as IgM, IgG2a and IgA [29, 30], which is
regulated via secretion of IFN-γ and IL-2 and via expres-
sion of CD40L [31]. Cytokine measurements in the cul-
ture supernatant of splenocytes from immunized guinea
pigs, after stimulation with our r4R protein, showed high
induction of IFN-γ compared with IL-4, which supports
that the r4R multi-epitope chimeric protein vaccine is
biased towards a Th1-type response.
Severe leptospirosis is typically associated with an
overactive host response that damages its own tissues,
such as the liver, kidney and lung, which can further-
more lead to hemorrhages. Guinea pigs are susceptible
to Leptospira infection and frequently present these
symptoms. In order to determine the ability of our r4R
protein to induce a protective immune response against
a Leptospira infection, guinea pigs were used as an infec-
tion model. Compared with unvaccinated guinea pigs,
immunized animals showed increased survival, reduced
tissue damage, decreased colonization of the kidneys
and reduced shedding of Leptospira in the urine.
However, immunized guinea pigs also showed some
inflammatory reactions, such as edema symptoms.
This may be the result of increased IFN-γ production
after immunization, which can cause inflammation or
a delayed type hypersensitivity [32].
Conclusions
This study showed that the chimeric multi-epitope pro-
tein r4R is a promising vaccine candidate for the devel-
opment of a universal vaccine against Leptospira
infections. Immunized guinea pigs showed a strong
antigen-specific humoral and cellular immune response,
a reduction in tissue damage and colonization and pro-
tection against a lethal Leptospira infection. Thus, the
multi-epitope chimeric r4R vaccine, containing both T-
and B-cell epitopes, may represent an effective antigen
to increase the efficacy of vaccines against leptospirosis.
Methods
Bacterial strains, media and plasmids
Escherichia coli host strains DH10B and BL21 (DE3) and
the plasmids pBacPAK8 and pET-28a (+) were main-
tained in the lab. The pGEM-T easy vector was obtained
from Promega (Wisconsin, USA). Endonucleases and
the DNA ladder were bought from TaKaRa Bio Co., Ltd
(Dalian, China). The protein molecular weight marker,
lymphocyte separation medium (guinea pig), mitomycin
and the CCK-8 kit were purchased from Beyotime Insti-
tute of Biotechnology (Jiangsu, China). All chemicals
were of analytical grade. The secondary antibody-
enzyme conjugates used in this study were obtained
from Jackson ImmunoResearch (Pennsylvania, USA) or
Santa Cruz (California, USA). The UltraEAL Western
Blot Detection System was purchased from Shanghai
Generay Biotech Co., Ltd (Shanghai, China). Sera from
rabbits immunized with inactivated L. interrogans sero-
var Icterohaemorrhagiae Lai were maintained in our lab
[16, 24, 33]. Leptospira strains are kept in our lab and
cultured in EMHJ medium at 28 °C. New Zealand white
rabbits were purchased from the Laboratory Animal
Center of Zhejiang University. Three-week-old guinea
pigs were purchased from Vital River Laboratories
(Beijing, China) and screened by the microscopic
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agglutination test to ensure that they were free of preex-
isting antibodies to Leptospira.
Design, expression and purification of chimeric peptide
Based on our previous studies, six OMP epitopes were
selected, which each were 11–27 amino acids in length
(Additional file 2) [21, 22]. Recombinant plasmids were
constructed and target proteins were expressed and
purified following methods published previously [34].
Briefly, a gene encoding six selected immunodominant
epitopes, which were spaced by a tetraglycine linker and
codon-optimized for E. coli translation, was synthesized.
In the 5′ end, a BamHI site was designed, and in the 3′
end, a BglII and an EcoRI site were designed and spaced
by the terminator sequence TAA. Through four time
consecutive cloning of the BamHI/EcoRI-digested gene
into its BglII/EcoRI site, the synthesized gene was repeated
in four copies in the plasmid pBacPAK8-4R as a single
gene. The multi-epitope gene was subsequently cloned
into the BamHI/EcoRI site of pET28a (pET28a-4R). Plas-
mid DNA of pET28a-4R was transformed into E. coli
BL21 (DE3) for protein expression. The recombinant pro-
tein was expressed and purified using Ni-NTA Superflow
resin (Biocolors, Shanghai, China). Possible endotoxin
contamination from E. coli BL21 (DE3) was removed from
the purified protein using the Detoxi-Gel Endotoxin Re-
moval kit (Thermo Scientific, USA) [35]. Using LPS from
E. coli serotype O111:B4 (Sigma) as control, a limulus test
was carried out to detect LPS in the purified protein sam-
ples according to the manufacturer’s protocol.
SDS-PAGE and Western blot for the detection of chimeric
antigens
To detect the recombinant 4R protein with antibodies
present in the serum of rabbits immunized with inacti-
vated L. interrogans cells, the purified target protein was
run on a 10 % SDS-PAGE gel, along with appropriate
controls and prestained protein markers. The proteins
were subsequently transferred to a polyvinylidene fluor-
ide membrane (PVDF, Millpore) following Bio-Rad Pro-
tocols. The membrane was incubated in 1 × TBST (Tris
buffered saline; 0.1 % Tween 20, pH 7.2) with 6 % new-
born bovine serum for 1 h at 37 °C, washed three times
with 1 × TBST and further incubated with rabbit anti-
Leptospira serum (1:1 000 dilution) for 1 h at 37 °C. The
membrane was washed three times with 1 × TBST, and
incubated with a goat anti-rabbit IgG-HRP conjugate
secondary antibody (1:5 000 dilution) for a further 1 h at
37 °C. Chemiluminescent detection was performed using
Lumigen-PS according to the manufacturer’s protocol
(GE) and blots were exposed against X-ray films for rele-
vant time periods.
Immunization of guinea pigs with purified recombinant
4R (r4R) protein and detection of the antibody response
For the safety test, guinea pigs (150 g ± 3 g, aged
3 weeks), were immunized with 200 μg r4R protein that
had been pre-mixed with aluminum hydroxide (1.0 mg/
ml, Sigma, USA). Administration was performed sub-
cutaneously in the four limbs and an equivalent booster
dose was given 14 days after the initial immunization.
After 7–10 days, guinea pigs were sacrificed for further
experiments. PBS immunized guinea pigs following the
same procedure were used as control.
The immunogenicity of the r4R protein was analyzed
by Western blot and ELISA. Blood collected from immu-
nized guinea pigs was allowed to clot overnight, centri-
fuged at 4500 rpm for 10 min and the sera were collected
and stored at −20 °C for further analysis. Western blot
analysis was carried out as described above using a 1:150
dilution of sera from r4R-immunized animals and a
1:5000 dilution of the goat anti-guinea pig IgG-HRP con-
jugate secondary antibody.
For ELISA analysis, 96-well ELISA plates were coated
with 0.5 μg/well of L. interrogans strain Lai diluted in
0.1 M Na2HPO4 (pH 9.0). After incubation overnight at
4 °C, the plates were washed three times with PBST
(phosphate-buffered saline containing 0.05 % Tween 20,
pH 7.4), blocked at 37 °C for 1 h with 100 μl of 1 % bo-
vine serum albumin (BSA) in PBS, and washed three
times with PBST. One hundred microliter optimal di-
luted (1:100) serum sample was added to each well and
incubated at 37 °C for 2 h. After washing, 100 μl of goat
anti-guinea pig IgG1 or IgG2a conjugated to horseradish
peroxidase (ICLLab) diluted (1:100) with 1 % BSA in
PBST was added to plates and incubated at 37 °C for
1 h. Following washing, 100 μl of concentrated 3,3′,5,5′-
tetramethylbenzidine substrate was allowed to react with
the HRP for 15 min at 37 °C in the dark. The color reac-
tion was stopped by adding 100 μl of 2 M H2SO4, and
the absorbance at a wavelength of 450 nm was read in a
microplate reader.
MAT was used to detect the agglutination of immune
sera with standard reference strains of Leptospira in
China [5]. Briefly, the sera from immunized guinea pigs
were diluted in a gradient (1:20, 1:40, 1:80, 1:160, 1:320
and 1:640) in normal saline and subsequently mixed
with the same volume of Leptospira cultures. After incu-
bated at 37 °C for 1 h, agglutination was determined by
dark-field microscopy. The agglutination titer was deter-
mined as the highest dilution of serum which causes
50 % of the Leptospira to agglutinate compared with the
negative control.
LD50 determination and challenge experiments
L. interrogans strain Lai was propagated for 3 weeks in
EMJH medium until dense cultures were observed using
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dark-field microscopy. The Leptospira were washed
three times by centrifugation at 12,000 rpm for 15 min
and resuspended in PBS. The suspension was then di-
luted to concentrations ranging from 1 × 107 to 1 × 1010
cells/ml. To calculate the 50 % lethal dose (LD50), guinea
pigs were divided into five groups, each containing six
guinea pigs. Four of the groups were given different con-
centrations of fresh Leptospira (107, 108, 109 and 1010
cells/ml)) intraperitoneally in 1 ml quantities. The ani-
mals of the control group were administered with
EMJH. The animals were monitored twice daily for up
to 21 days post challenge to record for signs of terminal
disease (moribund), which was counted as dead. The
surviving animals were recorded for calculating the LD50
using the probit analysis [36]. In the vaccine trial, the
guinea pigs were divided into three groups, each with
five animals. Animals from A group were used as unvac-
cinated healthy controls. Animals from group B were
immunized with 200 μg r4R protein supplemented with
aluminum hydroxide (1.0 mg/ml. Sigma, USA) as adju-
vant. Booster doses of the same vaccine were given at
2 week intervals. Animals from group C were immu-
nized with PBS and used as control animals. The guinea
pigs in group B and C were challenged intraperitoneally
with a 2 × LD50 of low-passage L. interrogans strain Lai
42 days after the initial immunization. The animals were
monitored twice daily to observe for clinical symptoms.
Urine samples, which were collected at weekly intervals
following challenge, were processed for the detection of
Leptospira. All animals were sacrificed and blood was
collected from the eyeground for antibody detection.
The tissues, including liver, kidney, spleen and lungs
were collected aseptically for further analysis. The pro-
tective efficacy of the chimeric protein was replicated
three times.
The kidneys of infected animals were homogenized in
EMJH medium and subsequently transferred into 5 ml
EMJH medium. After incubation at 30 °C for 28 days,
the culture samples were monitored for growth. A tung-
sten lamp was used to determine the turbidity of the
EMJH medium and after Fontana silver staining, the
samples were observed using an optical microscope.
Histopathology
Tissues from guinea pigs were immersed in 10 % neutral
formaldehyde solution for 48 h, and then rinsed, dehydrated
and embedded in paraffin. Tissue sections were stained with
hematoxylin and eosin (H&E) using standard histological
techniques, and examined by light microscopy [8, 37].
CD4+ T lymphocyte proliferative response and cytokine
evaluation
Spleens were aseptically removed from immunized guinea
pigs and mechanically homogenized with a syringe plunger.
The splenic T lymphocytes were isolated using lymphocyte
separation medium (guinea pig) according to the manufac-
turer’s protocols, and the cells were suspended in complete
RPMI-1640 media (RPMI-1640, 10 % fetal bovine serum,
2 mM glutamine, 50 U of penicillin/ml, 50 μg of strepto-
mycin/ml, 50 μM 2-mercaptoethanol, and 25 mM HEPES).
Lymphocyte proliferation was evaluated using the
CCK-8 assay kit as described previously [22]. Aliquots of
5 × 105 splenic lymphocytes were dispensed into 96-well
flat-bottomed microtiter plates and incubated at 37 °C
with 5 % CO2 for 7 days in the presence of 5 μg poke-
weed mitogen/ml and 2 μg purified r4R protein. Cells
suspended in PBS were used as negative control, and the
mitogen Concanavalin A (ConA, at a final concentration
of 1 μg/ml) was used as positive control.
To determine the cytokine secretion pattern and
evaluate Th cell polarization, cytokine levels in the
supernatant of the cell culture (100 μl each) were evalu-
ated using guinea pig IFN-γ or IL-4 ELISA kits (Westang,
Shanghai). The cytokine levels were calculated by titration
of supplied calibrated cytokine standards. All assays were
performed as suggested by the manufacturer. The level of
cytokines in the medium was calculated for each sample
by subtracting the corresponding cytokine concentration
produced in the control wells without antigen.
Statistical analysis
Figures represent data from three independent experi-
ments, and the data were expressed as mean ± standard
deviation (S.D.). Microsoft office Excel was used to
analyze variance and identify significant differences.
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